<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pan X</submitter><funding>National Natural Science Foundation of China</funding><pagination>100775</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8515245</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Polycystic ovary syndrome (PCOS) is one of the most common causes of anovulatory infertility. Chinese herbal medicine (CHM) has many advantages in treating PCOS. We conducted a retrospective cohort study to investigate the effects of CHM (Bu-Shen-Tian-Jing Formula, BSTJF) on the outcomes of IVF in Chinese patients with PCOS and the potential underlying mechanism.&lt;h4>Methods&lt;/h4>A total of 111 patients with PCOS who undergone IVF between November 2009 and July 2018 were included. Fifty-four patients received a three-month BSTJF therapy before controlled ovarian hyperstimulation, while the other 57 patients didn't. The data of the PCOS patients was collected. Anti-Müllerian hormone (AMH), growth differentiation factor-8 (GDF-8) levels in the follicular fluid were evaluated</pubmed_abstract><journal>Integrative medicine research</journal><pubmed_title>Chinese herbal medicine (Bu-Shen-Tian-Jing Formula) for outcomes of IVF in Chinese patients with polycystic ovary syndrome: a retrospective cohort study.</pubmed_title><pmcid>PMC8515245</pmcid><funding_grant_id>81873837</funding_grant_id><funding_grant_id>82074476</funding_grant_id><funding_grant_id>81874480</funding_grant_id><pubmed_authors>Pan X</pubmed_authors><pubmed_authors>Shi B</pubmed_authors><pubmed_authors>Gu Y</pubmed_authors><pubmed_authors>Cui L</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Qu F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chinese herbal medicine (Bu-Shen-Tian-Jing Formula) for outcomes of IVF in Chinese patients with polycystic ovary syndrome: a retrospective cohort study.</name><description>&lt;h4>Background&lt;/h4>Polycystic ovary syndrome (PCOS) is one of the most common causes of anovulatory infertility. Chinese herbal medicine (CHM) has many advantages in treating PCOS. We conducted a retrospective cohort study to investigate the effects of CHM (Bu-Shen-Tian-Jing Formula, BSTJF) on the outcomes of IVF in Chinese patients with PCOS and the potential underlying mechanism.&lt;h4>Methods&lt;/h4>A total of 111 patients with PCOS who undergone IVF between November 2009 and July 2018 were included. Fifty-four patients received a three-month BSTJF therapy before controlled ovarian hyperstimulation, while the other 57 patients didn't. The data of the PCOS patients was collected. Anti-Müllerian hormone (AMH), growth differentiation factor-8 (GDF-8) levels in the follicular fluid were evaluated</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T09:40:14.57Z</modification><creation>2025-04-04T09:40:14.57Z</creation></dates><accession>S-EPMC8515245</accession><cross_references><pubmed>34692411</pubmed><doi>10.1016/j.imr.2021.100775</doi></cross_references></HashMap>